Advertisement

Index by author

July 01, 2004; Volume 32,Issue 7

  1. Sekikawa, Kenji

    1. INVOLVEMENT OF INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR α IN CYP3A11 AND 2C29 DOWN-REGULATION BY BACILLUS CALMETTE-GUÉRIN AND LIPOPOLYSACCHARIDE IN MOUSE LIVER
      Takashi Ashino, Takiko Oguro, Seiji Shioda, Reiko Horai, Masahide Asano, Kenji Sekikawa, Yoichiro Iwakura, Satoshi Numazawa and Takemi Yoshida
      Drug Metabolism and Disposition July 2004, 32 (7) 707-714; DOI: https://doi.org/10.1124/dmd.32.7.707

  2. Serabjit-singh, Cosette J.

    1. THE SYSTEMIC EXPOSURE OF AN N-METHYL-d-ASPARTATE RECEPTOR ANTAGONIST IS LIMITED IN MICE BY THE P-GLYCOPROTEIN AND BREAST CANCER RESISTANCE PROTEIN EFFLUX TRANSPORTERS
      Joseph W. Polli, Todd M. Baughman, Joan E. Humphreys, Kelly H. Jordan, Angela L. Mote, Lindsey O. Webster, Robert J. Barnaby, Giovanni Vitulli, Luigina Bertolotti, Kevin D. Read and Cosette J. Serabjit-Singh
      Drug Metabolism and Disposition July 2004, 32 (7) 722-726; DOI: https://doi.org/10.1124/dmd.32.7.722

  3. Shetty, Bhasker V.

    1. METABOLISM AND EXCRETION OF CAPRAVIRINE, A NEW NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR, ALONE AND IN COMBINATION WITH RITONAVIR IN HEALTHY VOLUNTEERS
      Hai-Zhi Bu, William F. Pool, Ellen Y. Wu, Susan R. Raber, Michael A. Amantea and Bhasker V. Shetty
      Drug Metabolism and Disposition July 2004, 32 (7) 689-698; DOI: https://doi.org/10.1124/dmd.32.7.689

  4. Shioda, Seiji

    1. INVOLVEMENT OF INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR α IN CYP3A11 AND 2C29 DOWN-REGULATION BY BACILLUS CALMETTE-GUÉRIN AND LIPOPOLYSACCHARIDE IN MOUSE LIVER
      Takashi Ashino, Takiko Oguro, Seiji Shioda, Reiko Horai, Masahide Asano, Kenji Sekikawa, Yoichiro Iwakura, Satoshi Numazawa and Takemi Yoshida
      Drug Metabolism and Disposition July 2004, 32 (7) 707-714; DOI: https://doi.org/10.1124/dmd.32.7.707

  5. Sinclair, Jacqueline F.

    1. ROLE OF MOUSE CYP2E1 IN THE O-HYDROXYLATION OF P-NITROPHENOL: COMPARISON OF ACTIVITIES IN HEPATIC MICROSOMES FROM CYP2E1(-/-) AND WILD-TYPE MICE
      Kristina K. Wolf, Sheryl G. Wood, Jenna L. Bement, Peter R. Sinclair, Steven A. Wrighton, Elizabeth Jeffery, Frank J. Gonzalez and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2004, 32 (7) 681-684; DOI: https://doi.org/10.1124/dmd.32.7.681

  6. Sinclair, Peter R.

    1. ROLE OF MOUSE CYP2E1 IN THE O-HYDROXYLATION OF P-NITROPHENOL: COMPARISON OF ACTIVITIES IN HEPATIC MICROSOMES FROM CYP2E1(-/-) AND WILD-TYPE MICE
      Kristina K. Wolf, Sheryl G. Wood, Jenna L. Bement, Peter R. Sinclair, Steven A. Wrighton, Elizabeth Jeffery, Frank J. Gonzalez and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2004, 32 (7) 681-684; DOI: https://doi.org/10.1124/dmd.32.7.681

  7. Sjoberg, Helena

    1. AN EVALUATION OF THE IN VITRO METABOLISM DATA FOR PREDICTING THE CLEARANCE AND DRUG-DRUG INTERACTION POTENTIAL OF CYP2C9 SUBSTRATES
      Tommy B. Andersson, Eva Bredberg, Hans Ericsson and Helena Sjöberg
      Drug Metabolism and Disposition July 2004, 32 (7) 715-721; DOI: https://doi.org/10.1124/dmd.32.7.715

  8. Slitt, Angela L.

    1. LIPOPOLYSACCHARIDE-MEDIATED REGULATION OF HEPATIC TRANSPORTER mRNA LEVELS IN RATS
      Nathan J. Cherrington, Angela L. Slitt, Ning Li and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2004, 32 (7) 734-741; DOI: https://doi.org/10.1124/dmd.32.7.734
Back to top

In this issue

Advertisement